206 related articles for article (PubMed ID: 20699387)
1. Targeting the endothelium to prevent diabetes-related atherosclerosis.
Kearney MT
Diab Vasc Dis Res; 2010 Jul; 7(3):177. PubMed ID: 20699387
[No Abstract] [Full Text] [Related]
2. Endothelial dysfunction and cardiovascular disease--the lull before the storm.
Marx N; Grant PJ
Diab Vasc Dis Res; 2007 Jun; 4(2):82-3. PubMed ID: 17654440
[No Abstract] [Full Text] [Related]
3. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
Otsuki M; Goya K; Kasayama S
Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction and vascular inflammation in type 2 diabetes: interaction of AGE/RAGE and TNF-alpha signaling.
Csiszar A; Ungvari Z
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H475-6. PubMed ID: 18599592
[No Abstract] [Full Text] [Related]
5. Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction.
Leo CH; Woodman OL
J Cardiovasc Pharmacol; 2015 Jun; 65(6):532-44. PubMed ID: 25387248
[TBL] [Abstract][Full Text] [Related]
6. Vascular reactivity in diabetes mellitus.
Dandona P
Endocrinol Nutr; 2009 Dec; 56 Suppl 4():12-4. PubMed ID: 20629223
[No Abstract] [Full Text] [Related]
7. Response to Buscemi S et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
Zaccardi F; Pitocco D; Caputo S; Ghirlanda G
Diabet Med; 2011 Jan; 28(1):126; author reply 127-8. PubMed ID: 21166858
[No Abstract] [Full Text] [Related]
8. Endothelial dysfunction and its role in diabetic vascular disease.
Hartge MM; Kintscher U; Unger T
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):551-60, viii-ix. PubMed ID: 16959585
[TBL] [Abstract][Full Text] [Related]
9. Effect of pioglitazone on endothelial function in impaired glucose tolerance.
Quinn CE; Lockhart CJ; Hamilton PK; Loughrey CM; McVeigh GE
Diabetes Obes Metab; 2010 Aug; 12(8):709-15. PubMed ID: 20590748
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents.
Dandona P; Aljada A
J Diabetes Complications; 2004; 18(2):91-102. PubMed ID: 15120703
[TBL] [Abstract][Full Text] [Related]
11. [Insulin resistance and atherosclerosis. Controlling diabetes on 2 fronts].
MMW Fortschr Med; 2003 Sep; 145(37):65. PubMed ID: 14584452
[No Abstract] [Full Text] [Related]
12. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
Lehmann DF; Lohray BB
J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
[No Abstract] [Full Text] [Related]
13. Changes in serum adiponectin concentrations and endothelial function after intensive insulin treatment in people with newly diagnosed type 2 diabetes: a pilot study.
Li F; Zhao T; Wen X
Diabetes Res Clin Pract; 2011 Nov; 94(2):186-92. PubMed ID: 21871685
[TBL] [Abstract][Full Text] [Related]
14. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.
Liang W; Tan CY; Ang L; Sallam N; Granville DJ; Wright JM; Laher I
J Physiol Sci; 2008 Dec; 58(6):405-11. PubMed ID: 18845058
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction and hypertension in diabetes mellitus.
Dandona P; Chaudhuri A; Aljada A
Med Clin North Am; 2004 Jul; 88(4):911-31, x-xi. PubMed ID: 15308385
[TBL] [Abstract][Full Text] [Related]
16. New advances in the management of insulin resistance in type 2 diabetes. Introduction.
Campbell IW; Charbonnel B
Int J Clin Pract Suppl; 2001 Sep; (121):3. PubMed ID: 11594242
[No Abstract] [Full Text] [Related]
17. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis.
Dong Y; Fernandes C; Liu Y; Wu Y; Wu H; Brophy ML; Deng L; Song K; Wen A; Wong S; Yan D; Towner R; Chen H
Diab Vasc Dis Res; 2017 Jan; 14(1):14-23. PubMed ID: 27941052
[TBL] [Abstract][Full Text] [Related]
18. Catechin averts experimental diabetes mellitus-induced vascular endothelial structural and functional abnormalities.
Bhardwaj P; Khanna D; Balakumar P
Cardiovasc Toxicol; 2014 Mar; 14(1):41-51. PubMed ID: 24048981
[TBL] [Abstract][Full Text] [Related]
19. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
Buscemi S; Re A; Batsis JA; Arnone M; Mattina A; Cerasola G; Verga S
Diabet Med; 2010 Aug; 27(8):872-8. PubMed ID: 20653743
[TBL] [Abstract][Full Text] [Related]
20. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
Mafrici A; Proietti R
G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
